Rebif 22 (HSA-haltige Formulierung)
Rebif 22 (HSA-haltige Formulierung) is a medicine authorised by Swissmedic under authorisation number 54810. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 December 1998 and the authorisation is valid without a time limit. ATC code L03AB07 places the medicine in the group Immunostimulants.
| Authorisation number | 54810 |
|---|---|
| Name | Rebif 22 (HSA-haltige Formulierung) |
| Full name | Rebif 22 (HSA-haltige Formulierung), Injektionslösung in Fertigspritzen |
| Authorisation holder | Merck (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L03AB07 |
| First authorisation | 23 December 1998 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rebif 22 (HSA-haltige Formulierung), Injektionslösung in Fertigspritzen | B | 23 December 1998 |
| 2 | Rebif 44 (HSA-haltige Formulierung), Injektionslösung in Fertigspritzen | B | 23 December 1998 |
| 3 | Rebif 8.8 (HSA-haltige Formulierung), Injektionslösung in Fertigspritzen | B | 20 December 2006 |
| 4 | Rebif 8.8 und 22, Injektionslösung in Fertigspritzen | B | 10 October 2008 |
| 5 | Rebif 22, Injektionslösung in Fertigspritzen | B | 10 October 2008 |
| 6 | Rebif 44, Injektionslösung in Fertigspritzen | B | 10 October 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 60 | 6 + 6 | Fertigspritze(n) | L03AB07 | 01.99.0. | B |
| 62 | 12 | Fertigspritze(n) | L03AB07 | 01.99.0. | B |
| 64 | 12 | Fertigspritze(n) | L03AB07 | 01.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rebif 22 (HSA-haltige Formulierung) authorised in Switzerland?
Yes. Rebif 22 (HSA-haltige Formulierung) is authorised by Swissmedic under authorisation number 54810, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rebif 22 (HSA-haltige Formulierung) have?
Rebif 22 (HSA-haltige Formulierung) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rebif 22 (HSA-haltige Formulierung)?
The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.